erythrosine has been researched along with semaxinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmin, S; Risling, M; Sköld, MK | 1 |
| Agoston, DV; Lee, C | 1 |
2 other study(ies) available for erythrosine and semaxinib
| Article | Year |
|---|---|
Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration.
Topics: Angiogenesis Inhibitors; Animals; Brain Injuries; Cell Count; Cell Death; Disease Models, Animal; Female; Fluoresceins; Glial Fibrillary Acidic Protein; Immunosorbent Techniques; In Situ Hybridization; In Situ Nick-End Labeling; Indoles; Microtubule-Associated Proteins; Myelin-Associated Glycoprotein; Nerve Degeneration; Nerve Growth Factors; Neuroglia; Organic Chemicals; Pyrroles; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury.
Topics: Animals; Brain Injuries; Cell Death; Dentate Gyrus; Fluoresceins; Fluorescent Dyes; Immunohistochemistry; In Situ Nick-End Labeling; Indoles; Injections, Intraventricular; Male; Neurons; Neuroprotective Agents; Organic Chemicals; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2009 |